Reuters Health Report: September 28, 2017

Click to View in Browser Thursday, September 28, 2017 Novartis forges UC Berkeley pact, sees drug hopefuls in three years ZURICH (Reuters) - Novartis's NOVN.S research head expects an alliance with a University of California chemistry lab to produce drug candidates within three years as the Swiss company accelerates its hunt for new medicines. Republicans fail again to kill off Obamacare in Senate WASHINGTON (Reuters) - U.S. Republicans on Tuesday fell short yet again in their seven-year drive to repeal Obamacare, in a bitter defeat that raises more questions about their ability to enact President Donald Trump's agenda. EU approves Sanofi and Regeneron's dupilumab in eczema PARIS (Reuters) - The European Commission approved Regeneron Pharmaceuticals' and Sanofi's key biologic treatment dupilumab for moderate-to-severe atopic dermatitis, the two companies said on Thursday. Senators want probe of Allergan transfer deal with tribe: letter (Reuters) - Four U.S. senators have asked the Senate Judiciary Committee to launch an investigation into a deal drugmaker Allergan Plc struck with a Native American tribe to protect some of its patents from generic challenge, according to a letter seen by Reuters. Merck KGaA eyes up to 700 million eur Mavenclad sales in EU FRANKFURT (Reuters) - Germany's Merck KGaA is eyeing annual sales of its multiple sclerosis pill Mavenclad, a late-comer to the market for oral treatments against the neurological disease, of up to 700 million euros ($823 million) in the European Union. Trump 'not happy' with U.S. health chief Price over private travel WASHINGTON (Reuters) - U.S. President Donald Trump said on Wednesday he was "not happy" with Health and Human Services Secretary Tom Price over reports he used expensive private charter jets to travel for government business rather than cheaper commercial flights. WHO reports 25 million unsafe abortions a year, sees higher risk from U.S. cutbacks GENEVA (Reuters) - Nearly half of the estimated 56 million abortions performed worldwide every year are unsafe and women in poor countries face even higher risks due to U.S. funding cuts to family planning programs abroad, health experts said on Thursday. Don't worry about 'tongue swallowing' in cardiac arrest victims (Reuters Health) - If someone in cardiac arrest needs cardiopulmonary resuscitation (CPR), don't waste time trying to move the person's tongue out of the way, experts say. FDA approves Abbott's blood glucose monitoring device (Reuters) - The U.S. Food and Drug Administration said it approved Abbott Laboratories' glucose monitoring device for adults with diabetes, allowing millions of people to track their blood sugar levels without having to prick their fingers. More evidence that even a little exercise is good for your heart (Reuters Health) - People with heart disease who are sedentary most of the time may be able to improve their survival odds by getting just a little bit of exercise, a recent study suggests. Related Video 'Smart' windows will lower heating costs, say researchers Starbucks UK to upcycle store waste into furniture A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook